Published human evidence includes topical applications over defined periods, diabetic-ulcer wound protocols, and a registered topical acute-wound trial, while there is no FDA-approved injectable GHK-Cu label that establishes a standard dose [2], [3], [7], [8]
As an amylin receptor agonist, Cagrilintide acts through a fundamentally different pathway compared to incretin-based peptides like Retatrutide
However, the best supplement routine is the one you can stick to
Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex
GHRP-6 has been linked to receptor activity in diverse tissues, suggesting wide receptor distribution, while Sermorelin has been studied more directly within anterior pituitary contexts
doi:10.1016/j.fertnstert.2018.05.027